Multi-organ dysfunction due to bath salts: are we aware of this entity?
| Autor: | David Cooper, Rohith Valsalan, Benoj Varghese, Diya Soman, S Yew, Jonathan Buckmaster |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Tachycardia
Disseminated intravascular coagulation medicine.medical_specialty business.industry 010401 analytical chemistry Methylenedioxypyrovalerone Metabolic acidosis medicine.disease 01 natural sciences 0104 chemical sciences Surgery 03 medical and health sciences 0302 clinical medicine Oliguria Anesthesia Internal Medicine medicine medicine.symptom Adverse effect business Rhabdomyolysis 030217 neurology & neurosurgery medicine.drug Bath salts |
| Zdroj: | Internal Medicine Journal. 47:109-111 |
| ISSN: | 1444-0903 |
| DOI: | 10.1111/imj.13307 |
| Popis: | Methylenedioxypyrovalerone (MDPV) is a synthetic, cathinone-derivative, central nervous system stimulant taken to produce a cocaine- or methamphetamine-like high. Physical manifestations include tachycardia, hypertension, arrhythmias, hyperthermia, sweating, rhabdomyolysis, hyperkalaemia, disseminated intravascular coagulation, oliguria and seizures. We report a patient who presented with severe metabolic acidosis, multi-organ dysfunction, rhabdomyolysis, hyperkalaemia and seizures. This case highlights that even though a urine drug screen for routine psychostimulant drugs is negative, clinicians need to be vigilant about the adverse effects of MDPV as a possible cause of multi-organ dysfunction. Substances such as this can only be detected by special tests, such as gas/liquid chromatography mass spectrometry. This is the first reported case of MDPV toxicity successfully treated in Australia to the best of our knowledge. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text